JACC: Advances - Lipoprotein(a): a residual cardiovascular risk factor in statin-treated stroke survivors - Insights from the SPARCL trial

JACC Specialty Journals

Sep 29 2023 • 2 mins

Commentary by Dr. Candice Silversides

You Might Like